Open Access 01-12-2019 | Dapagliflozin | Commentary
Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible
Published in: Cardiovascular Diabetology | Issue 1/2019
Login to get access